4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-25-022069
SVP & GENERAL COUNSEL sold 771 shares at an average $24.77 ($19,096)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2025-08-13 | Sale | −341 | $23.95 | $8,167 | 35,392 | D |
| Jimenez Freddy A. SVP & GENERAL COUNSEL | 2025-08-13 | Sale | −430 | $25.42 | $10,928 | 34,962 | D |
| Open-market sales · 771 sh · avg $24.77 · $19,096 | |||||||
Loading xslF345X05/form4-08152025_080825.xml…